BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17157204)

  • 1. Tolerogenic response: allorecognition pathways.
    Caballero A; Fernandez N; Lavado R; Bravo MJ; Miranda JM; Alonso A
    Transpl Immunol; 2006 Dec; 17(1):3-6. PubMed ID: 17157204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection mechanisms in transplantation.
    Game DS; Warrens AN; Lechler RI
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):832-8. PubMed ID: 11732119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect allorecognition in solid organ transplantation.
    Harris PE; Cortesini R; Suciu-Foca N
    Rev Immunogenet; 1999; 1(3):297-308. PubMed ID: 11256421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alloresponse.
    Hernandez-Fuentes MP; Baker RJ; Lechler RI
    Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
    Jiang S; Herrera O; Lechler RI
    Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect allorecognition.
    Hornick P
    Methods Mol Biol; 2006; 333():145-56. PubMed ID: 16790850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of liver allograft rejection: the indirect recognition pathway.
    Molajoni ER; Cinti P; Orlandini A; Molajoni J; Tugulea S; Ho E; Liu Z; Suciu-Foca N; Cortesini R
    Hum Immunol; 1997 Mar; 53(1):57-63. PubMed ID: 9127148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basis of immunogenicity of endocrine allografts.
    Nicolls MR; Coulombe M; Gill RG
    Crit Rev Immunol; 2001; 21(1-3):87-101. PubMed ID: 11642616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alloimmune response and effector mechanisms of allograft rejection.
    Arakelov A; Lakkis FG
    Semin Nephrol; 2000 Mar; 20(2):95-102. PubMed ID: 10746853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of indirect allorecognition: wishful thinking or solid data?
    Waanders MM; Heidt S; Koekkoek KM; Zoet YM; Doxiadis II; Amir A; Heemskerk MH; Mulder A; Brand A; Roelen DL; Claas FH
    Tissue Antigens; 2008 Jan; 71(1):1-15. PubMed ID: 18096006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
    Thorsby E; Pfeffer P; Leivestad T
    Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of indirect allorecognition in long-term human renal transplantation.
    Coelho V; Spadafora-Ferreira M; Marrero I; Fonseca JA; Portugal K; Kalil J
    Clin Immunol; 1999 Feb; 90(2):220-9. PubMed ID: 10080834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunotherapeutic strategies using MHC derived peptides.
    Sayegh MH; Krensky AM
    Kidney Int Suppl; 1996 Jan; 53():S13-20. PubMed ID: 8770986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in transplant tolerance.
    Nouri-Shirazi M
    Iran J Immunol; 2007 Mar; 4(1):1-14. PubMed ID: 17652838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring.
    Korin YD; Lee C; Gjertson DW; Wilkinson AH; Pham TP; Danovitch GM; Gritsch HA; Reed EF
    Hum Immunol; 2005 Nov; 66(11):1110-24. PubMed ID: 16571412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.